BYSI

BeyondSpring Inc. is a leading clinical-stage biopharmaceutical company based in New York, dedicated to advancing innovative immuno-oncology therapies to address unmet medical needs in cancer treatment. With a robust pipeline that includes its lead candidate, which has shown promising results in clinical trials, BeyondSpring aims to enhance the efficacy and safety of cancer care. By leveraging cutting-edge scientific research and strong partnerships, the company is positioned to make significant contributions to the field of oncology and deliver transformative therapies to patients worldwide.